Stoppa-Lyonnet D - Search Results

1

Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome.

This P, de la Rochefordière A, Savignoni A, Falcou MC, Tardivon A, Thibault F, Alran S, Fourchotte V, Fitoussi A, Couturaud B, Dolbeault S, Salmon RJ, Sigal-Zafrani B, Asselain B, Stoppa-Lyonnet D; Institut Curie Breast and Ovarian Cancer Risk Study Group. This P, et al. Fam Cancer. 2012 Sep;11(3):473-82. doi: 10.1007/s10689-012-9539-1. Fam Cancer. 2012. PMID: 22711610 Clinical Trial.

2

Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer.

Eisinger F, Stoppa-Lyonnet D, Longy M, Kerangueven F, Noguchi T, Bailly C, Vincent-Salomon A, Jacquemier J, Birnbaum D, Sobol H. Eisinger F, et al. Cancer Res. 1996 Feb 1;56(3):471-4. Cancer Res. 1996. PMID: 8564955

3

Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers.

Sobol H, Stoppa-Lyonnet D, Bressac-de-Paillerets B, Peyrat JP, Kerangueven F, Janin N, Noguchi T, Eisinger F, Guinebretiere JM, Jacquemier J, Birnbaum D. Sobol H, et al. Cancer Res. 1996 Jul 15;56(14):3216-9. Cancer Res. 1996. PMID: 8764110

4

BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group.

Stoppa-Lyonnet D, Laurent-Puig P, Essioux L, Pagès S, Ithier G, Ligot L, Fourquet A, Salmon RJ, Clough KB, Pouillart P, Bonaïti-Pellié C, Thomas G. Stoppa-Lyonnet D, et al. Am J Hum Genet. 1997 May;60(5):1021-30. Am J Hum Genet. 1997. PMID: 9150149 Free PMC article.

5

[Genetic predispositions to breast cancer].

Stoppa-Lyonnet D. Stoppa-Lyonnet D. Presse Med. 1997 Dec 20;26(40):1978-80. Presse Med. 1997. PMID: 9537001 French.

6

Mutations at BRCA1: the medullary breast carcinoma revisited.

Eisinger F, Jacquemier J, Charpin C, Stoppa-Lyonnet D, Bressac-de Paillerets B, Peyrat JP, Longy M, Guinebretière JM, Sauvan R, Noguchi T, Birnbaum D, Sobol H. Eisinger F, et al. Cancer Res. 1998 Apr 15;58(8):1588-92. Cancer Res. 1998. PMID: 9563465

7

Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group.

Ansquer Y, Gautier C, Fourquet A, Asselain B, Stoppa-Lyonnet D. Ansquer Y, et al. Lancet. 1998 Aug 15;352(9127):541. doi: 10.1016/s0140-6736(05)79248-5. Lancet. 1998. PMID: 9716060 No abstract available.

8

[INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and/or ovarian cancer].

Eisinger F, Alby N, Bremond A, Dauplat J, Espié M, Janiaud P, Kuttenn F, Lebrun JP, Lefranc JP, Pierret J, Sobol H, Stoppa-Lyonnet D, Thouvenin D, Tristant H, Feingold J. Eisinger F, et al. Ann Genet. 1999;42(1):51-64. Ann Genet. 1999. PMID: 10214508 French.

9

Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families.

Janin N, Andrieu N, Ossian K, Laugé A, Croquette MF, Griscelli C, Debré M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D. Janin N, et al. Br J Cancer. 1999 Jun;80(7):1042-5. doi: 10.1038/sj.bjc.6690460. Br J Cancer. 1999. PMID: 10362113 Free PMC article.

10

No evidence for germline PTEN mutations in families with breast and brain tumours.

Laugé A, Lefebvre C, Laurent-Puig P, Caux V, Gad S, Eng C, Longy M, Stoppa-Lyonnet D. Laugé A, et al. Int J Cancer. 1999 Jun 21;84(3):216-9. doi: 10.1002/(sici)1097-0215(19990621)84:3<216::aid-ijc3>3.0.co;2-e. Int J Cancer. 1999. PMID: 10371336

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

492 results

Search Page

Filters